These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9179773)
41. Hepatitis B surface antigen on subviral particles reduces the neutralizing effect of anti-HBs antibodies on hepatitis B viral particles in vitro. Rydell GE; Prakash K; Norder H; Lindh M Virology; 2017 Sep; 509():67-70. PubMed ID: 28605637 [TBL] [Abstract][Full Text] [Related]
42. CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells. Schreiber S; Dressler LS; Loffredo-Verde E; Asen T; Färber S; Wang W; Groll T; Chakraborty A; Kolbe F; Kreer C; Kosinska AD; Simon S; Urban S; Klein F; Riddell SR; Protzer U Front Immunol; 2024; 15():1340619. PubMed ID: 38711498 [TBL] [Abstract][Full Text] [Related]
43. Expression of the PreS1 peptide of hepatitis B virus and preparation of its polyclonal antibody. Chen W; Zhang J; Zhang J; Wang D; Li Y; Huang A Hybridoma (Larchmt); 2011 Dec; 30(6):525-30. PubMed ID: 22149277 [TBL] [Abstract][Full Text] [Related]
44. Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein. Lambert V; Fernholz D; Sprengel R; Fourel I; Deléage G; Wildner G; Peyret C; Trépo C; Cova L; Will H J Virol; 1990 Mar; 64(3):1290-7. PubMed ID: 1689393 [TBL] [Abstract][Full Text] [Related]
45. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen. Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129 [TBL] [Abstract][Full Text] [Related]
46. Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins. Hu WG; Wei J; Xia HC; Yang XX; Li F; Li GD; Wang Y; Zhang ZC World J Gastroenterol; 2005 Apr; 11(14):2088-94. PubMed ID: 15810073 [TBL] [Abstract][Full Text] [Related]
47. Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg). Shin YW; Ryoo KH; Hong KW; Chang KH; Choi JS; So M; Kim PK; Park JY; Bong KT; Kim SH Antiviral Res; 2007 Aug; 75(2):113-20. PubMed ID: 17343928 [TBL] [Abstract][Full Text] [Related]
48. Characterization of a murine-human chimeric antibody with specificity for the pre-S2 surface antigen of hepatitis B virus expressed in baculovirus-infected insect cells. Jin BR; Ryu CJ; Kang SK; Han MH; Hong HJ Virus Res; 1995 Oct; 38(2-3):269-77. PubMed ID: 8578864 [TBL] [Abstract][Full Text] [Related]
49. Robust Zhang YL; Gao Y; Cao JL; Zhao JH; Zhang TY; Yang CL; Xiong HL; Wang YB; Ou SH; Cheng T; Chen CR; Yuan Q; Xia NS Emerg Microbes Infect; 2019; 8(1):724-733. PubMed ID: 31130075 [TBL] [Abstract][Full Text] [Related]
50. Generation and characterization of a novel tetravalent bispecific antibody that binds to hepatitis B virus surface antigens. Park SS; Ryu CJ; Kang YJ; Kashmiri SV; Hong HJ Mol Immunol; 2000 Dec; 37(18):1123-30. PubMed ID: 11451417 [TBL] [Abstract][Full Text] [Related]
51. Epitope mapping of the PreS1 domain of the hepatitis B virus large surface protein. Kuroki K; Floreani M; Mimms LT; Ganem D Virology; 1990 Jun; 176(2):620-4. PubMed ID: 1693249 [TBL] [Abstract][Full Text] [Related]
52. Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes. Neurath AR; Kent SB; Strick N; Parker K; Courouce AM; Riottot MM; Petit MA; Budkowska A; Girard M; Pillot J Mol Immunol; 1987 Sep; 24(9):975-80. PubMed ID: 3657811 [TBL] [Abstract][Full Text] [Related]
53. Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus. Cheung RC; Robinson WS; Marion PL; Greenberg HB J Virol; 1989 Jun; 63(6):2445-51. PubMed ID: 2470915 [TBL] [Abstract][Full Text] [Related]
54. PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Petit MA; Capel F; Dubanchet S; Mabit H Virology; 1992 Mar; 187(1):211-22. PubMed ID: 1736525 [TBL] [Abstract][Full Text] [Related]
55. A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations. Wang Q; Michailidis E; Yu Y; Wang Z; Hurley AM; Oren DA; Mayer CT; Gazumyan A; Liu Z; Zhou Y; Schoofs T; Yao KH; Nieke JP; Wu J; Jiang Q; Zou C; Kabbani M; Quirk C; Oliveira T; Chhosphel K; Zhang Q; Schneider WM; Jahan C; Ying T; Horowitz J; Caskey M; Jankovic M; Robbiani DF; Wen Y; de Jong YP; Rice CM; Nussenzweig MC Cell Host Microbe; 2020 Aug; 28(2):335-349.e6. PubMed ID: 32504577 [TBL] [Abstract][Full Text] [Related]
56. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response. Waters JA; Brown SE; Steward MW; Howard CR; Thomas HC Virus Res; 1992 Jan; 22(1):1-12. PubMed ID: 1371369 [TBL] [Abstract][Full Text] [Related]
57. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus. Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531 [TBL] [Abstract][Full Text] [Related]
58. Characterization of neutralizing anti-pre-S1 and anti-pre-S2 (HBV) monoclonal antibodies and their fragments. Küttner G; Kramer A; Schmidtke G; Giessmann E; Dong L; Roggenbuck D; Scholz C; Seifert M; Stigler RD; Schneider-Mergener J; Porstmann T; Höhne W Mol Immunol; 1999 Jul; 36(10):669-83. PubMed ID: 10509818 [TBL] [Abstract][Full Text] [Related]
59. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine. Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595 [TBL] [Abstract][Full Text] [Related]
60. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection. Fei GZ; Sylvan SP; Hellström UB; Yao GB J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]